1 / 8

Artificial Pancreas Device System Market : Growth opportunities through 2025

Artificial pancreas device system are the devices that closely copy the glucose regulating function of fit pancreas. The device not only monitors the glucose levels in the body, it also automatically adjusts the distribution of insulin to reduce high blood glucose levels and lowers the incidence of low blood glucose with less or no input from the patient.<br><br>Read More :-https://www.theinsightpartners.com/reports/artificial-pancreas-device-system-market<br>

Karan45
Télécharger la présentation

Artificial Pancreas Device System Market : Growth opportunities through 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Artificial Pancreas Device System Market Global Analysis and Forecast to 2025 Published Date : Jan 2019 Email: sales@theinsightpartners.com

  2. Email:sales@theinsightpartners.com Report Studies • Artificial Pancreas Device System Market to 2025 - Global Analysis and Forecasts by Type (Control to Range, Control to Target and Threshold Suspended Device Systems); and Geography

  3. Email:sales@theinsightpartners.com Artificial Pancreas Device System Market Value CAGR of 20.9% (2016 to 2025)

  4. Email:sales@theinsightpartners.com Artificial Pancreas Device System Market Overview • The artificial pancreas device systems market was valued at US$ 481.8 million in 2017 and it is projected to reach US$ 2,168.1 million in 2025; it is expected to grow at a CAGR of 20.9% from 2016 to 2025. • The report highlights the trends prevalent in the global artificial pancreas device systems market and the factors driving the market along with those that act as deterrents to its growth.

  5. Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • Type (Control to Range, Control to Target and Threshold Suspended Device Systems)

  6. Email:sales@theinsightpartners.com Company Profiles • Defymed • TypeZero Technologies, Inc. • Insulet Corporation • Bigfoot Biomedical, Inc. • Medtronic • Dexcom, Inc. • Admetsys • Beta Bionics • Cellnovo • Tandem Diabetes Care, Inc. Download Sample Here

  7. Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  8. THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related